May 16, 2023 — Royal Philips, a global leader in health technology, announced late-breaking data from the DCR4Contrast ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
February 9, 2023 — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has entered into a long ...
January 2, 2023 — The U.S. Food and Drug Administration (FDA) has approved the Stellarex 0.035” OTW Drug-coated ...
September 15, 2022 — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, will showcase its ...
September 12, 2022 — Royal Philips, a global leader in health technology, announced new milestones in the development of ...
August 30, 2022 — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, will showcase its latest ...
Enhanced features on the Philips EPIQ CVx ultrasound system provide a next level photorealistic 3D rendering, making it ...
Automated features on the Philips EPIQ CVx cardiology ultrasound system are helping to bring consistency and speed to ...
The X5-1c transducer from Philips provides enhanced clinical information in transthoracic imaging over a standard phased ...